Evidence map›Paper›PMID 40540129›Full record

ArticleEJNMMI research2025

Reduced splenic uptake of [

Qingqing Pan, Zhenying Chen, Silu Liu, Hongzhe Zhang, Jie Feng, Weibing Miao, Fang Li, Xinxin Cao, Yaping Luo

2 registry-linked trialsAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03436342 early_phase1unknown statusnot on this map

Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma

TypeinterventionalSponsorPeking Union Medical College HospitalRan2019 to 2020Enrolled100ConditionsMultiple Myeloma, LymphomaArms68Ga-Pentixafor
NCT04504526 early_phase1recruitingnot on this map

Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

TypeinterventionalSponsorFirst Affiliated Hospital of Fujian Medical UniversityRan2020 to 2027Enrolled50ConditionsLymphoma, Multiple Myeloma, LeukemiaArms68Ga-Pentixafor
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qingqing Pan *Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID http://orcid.org/0000-0003-2815-0767
Zhenying Chen *Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, China.
Silu LiuDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hongzhe ZhangDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jie FengDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Weibing MiaoDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, China.
Fang LiDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinxin CaoDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. luoyaping@live.com.
Yaping LuoDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. caoxinxin@126.com.ORCID http://orcid.org/0000-0002-5787-1136

Funding

CAMS Innovation Fund for Medical Sciences CIFMS, 2024-I2M-C&T-B-034National High Level Hospital Clinical Research Funding 2022-PUMCH-B-070National High Level Hospital Clinical Research Funding 2022-PUMCH-B-071Peking Union Medical College Hospital Talent Cultivation Program UBJ10707
6 · The paper itself

Abstract

backgroundWe aim to investigate the prognostic value of [

resultsThis is a retrospective analysis of a prospective cohort study. Twenty-five patients with treatment-naïve, newly diagnosed MM were included. All participants underwent [

conclusionReduced splenic uptake of [

trial registrationClinicalTrials. NCT03436342 Registered 25 October 2017, https://register. CLINICALTRIALS: gov/prs/app/action/SelectProtocol?sid=S0007IL2&selectaction=Edit&uid=U0001JRW&ts=6&cx=-3sdpwu . CLINICALTRIALS: NCT04504526 Registered 6 August 2020, https://clinicaltrials.gov/study/NCT04504526?cond=NCT04504526&rank=1 .

Indexed as

[68Ga]Ga-PentixaforMultiple myelomaPET/CTSpleen

Identifiers

PMID40540129
PMCPMC12181446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.